Glioma Diagnosis and Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 102 pages | ID: GEBE9328AAB4EN
Market Monitor Global

Abstracts

A glioma is a type of tumor that originates in the brain and is also known as a primary brain tumor. There are numerous types of gliomas which are entitled based on the origin of the cell type including oligodendrogliomas, astrocytoma, ependymomas, and glioblastoma. Nearly 33 percent of all brain tumors are gliomas.

This report contains market size and forecasts of Glioma Diagnosis and Treatment in Global, including the following market information:

Global Glioma Diagnosis and Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Glioma Diagnosis and Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Diagnosis (CT, MRI) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Glioma Diagnosis and Treatment include Thermo Fisher Scientific, Emcure Pharmaceuticals, Sigma-Aldrich, Pfizer, Taj Pharmaceuticals, Novartis International, Teva Pharmaceutical, GE Healthcare and Siemens Healthcare, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glioma Diagnosis and Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Glioma Diagnosis and Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Glioma Diagnosis and Treatment Market Segment Percentages, by Type, 2021 (%)

• Diagnosis (CT, MRI)
• Treatment (Surgery, Chemotherapy)

Global Glioma Diagnosis and Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Glioma Diagnosis and Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics

Global Glioma Diagnosis and Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Glioma Diagnosis and Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Glioma Diagnosis and Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Glioma Diagnosis and Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• Emcure Pharmaceuticals
• Sigma-Aldrich
• Pfizer
• Taj Pharmaceuticals
• Novartis International
• Teva Pharmaceutical
• GE Healthcare
• Siemens Healthcare
• Philips Healthcare
• Shimadzu
• Canon Medical Systems
• Merck
• Roche
• Arbor Pharmaceuticals
• Sun Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Glioma Diagnosis and Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Glioma Diagnosis and Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GLIOMA DIAGNOSIS AND TREATMENT OVERALL MARKET SIZE

2.1 Global Glioma Diagnosis and Treatment Market Size: 2021 VS 2028
2.2 Global Glioma Diagnosis and Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Glioma Diagnosis and Treatment Players in Global Market
3.2 Top Global Glioma Diagnosis and Treatment Companies Ranked by Revenue
3.3 Global Glioma Diagnosis and Treatment Revenue by Companies
3.4 Top 3 and Top 5 Glioma Diagnosis and Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Glioma Diagnosis and Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Glioma Diagnosis and Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Glioma Diagnosis and Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Glioma Diagnosis and Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Glioma Diagnosis and Treatment Market Size Markets, 2021 & 2028
  4.1.2 Diagnosis (CT, MRI)
  4.1.3 Treatment (Surgery, Chemotherapy)
4.2 By Type - Global Glioma Diagnosis and Treatment Revenue & Forecasts
  4.2.1 By Type - Global Glioma Diagnosis and Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Glioma Diagnosis and Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Glioma Diagnosis and Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Glioma Diagnosis and Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
5.2 By Application - Global Glioma Diagnosis and Treatment Revenue & Forecasts
  5.2.1 By Application - Global Glioma Diagnosis and Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Glioma Diagnosis and Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Glioma Diagnosis and Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Glioma Diagnosis and Treatment Market Size, 2021 & 2028
6.2 By Region - Global Glioma Diagnosis and Treatment Revenue & Forecasts
  6.2.1 By Region - Global Glioma Diagnosis and Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Glioma Diagnosis and Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Glioma Diagnosis and Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Glioma Diagnosis and Treatment Revenue, 2017-2028
  6.3.2 US Glioma Diagnosis and Treatment Market Size, 2017-2028
  6.3.3 Canada Glioma Diagnosis and Treatment Market Size, 2017-2028
  6.3.4 Mexico Glioma Diagnosis and Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Glioma Diagnosis and Treatment Revenue, 2017-2028
  6.4.2 Germany Glioma Diagnosis and Treatment Market Size, 2017-2028
  6.4.3 France Glioma Diagnosis and Treatment Market Size, 2017-2028
  6.4.4 U.K. Glioma Diagnosis and Treatment Market Size, 2017-2028
  6.4.5 Italy Glioma Diagnosis and Treatment Market Size, 2017-2028
  6.4.6 Russia Glioma Diagnosis and Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Glioma Diagnosis and Treatment Market Size, 2017-2028
  6.4.8 Benelux Glioma Diagnosis and Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Glioma Diagnosis and Treatment Revenue, 2017-2028
  6.5.2 China Glioma Diagnosis and Treatment Market Size, 2017-2028
  6.5.3 Japan Glioma Diagnosis and Treatment Market Size, 2017-2028
  6.5.4 South Korea Glioma Diagnosis and Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Glioma Diagnosis and Treatment Market Size, 2017-2028
  6.5.6 India Glioma Diagnosis and Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Glioma Diagnosis and Treatment Revenue, 2017-2028
  6.6.2 Brazil Glioma Diagnosis and Treatment Market Size, 2017-2028
  6.6.3 Argentina Glioma Diagnosis and Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Glioma Diagnosis and Treatment Revenue, 2017-2028
  6.7.2 Turkey Glioma Diagnosis and Treatment Market Size, 2017-2028
  6.7.3 Israel Glioma Diagnosis and Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Glioma Diagnosis and Treatment Market Size, 2017-2028
  6.7.5 UAE Glioma Diagnosis and Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific Glioma Diagnosis and Treatment Major Product Offerings
  7.1.4 Thermo Fisher Scientific Glioma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 Emcure Pharmaceuticals
  7.2.1 Emcure Pharmaceuticals Corporate Summary
  7.2.2 Emcure Pharmaceuticals Business Overview
  7.2.3 Emcure Pharmaceuticals Glioma Diagnosis and Treatment Major Product Offerings
  7.2.4 Emcure Pharmaceuticals Glioma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.2.5 Emcure Pharmaceuticals Key News
7.3 Sigma-Aldrich
  7.3.1 Sigma-Aldrich Corporate Summary
  7.3.2 Sigma-Aldrich Business Overview
  7.3.3 Sigma-Aldrich Glioma Diagnosis and Treatment Major Product Offerings
  7.3.4 Sigma-Aldrich Glioma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.3.5 Sigma-Aldrich Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Glioma Diagnosis and Treatment Major Product Offerings
  7.4.4 Pfizer Glioma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Key News
7.5 Taj Pharmaceuticals
  7.5.1 Taj Pharmaceuticals Corporate Summary
  7.5.2 Taj Pharmaceuticals Business Overview
  7.5.3 Taj Pharmaceuticals Glioma Diagnosis and Treatment Major Product Offerings
  7.5.4 Taj Pharmaceuticals Glioma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.5.5 Taj Pharmaceuticals Key News
7.6 Novartis International
  7.6.1 Novartis International Corporate Summary
  7.6.2 Novartis International Business Overview
  7.6.3 Novartis International Glioma Diagnosis and Treatment Major Product Offerings
  7.6.4 Novartis International Glioma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.6.5 Novartis International Key News
7.7 Teva Pharmaceutical
  7.7.1 Teva Pharmaceutical Corporate Summary
  7.7.2 Teva Pharmaceutical Business Overview
  7.7.3 Teva Pharmaceutical Glioma Diagnosis and Treatment Major Product Offerings
  7.7.4 Teva Pharmaceutical Glioma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.7.5 Teva Pharmaceutical Key News
7.8 GE Healthcare
  7.8.1 GE Healthcare Corporate Summary
  7.8.2 GE Healthcare Business Overview
  7.8.3 GE Healthcare Glioma Diagnosis and Treatment Major Product Offerings
  7.8.4 GE Healthcare Glioma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.8.5 GE Healthcare Key News
7.9 Siemens Healthcare
  7.9.1 Siemens Healthcare Corporate Summary
  7.9.2 Siemens Healthcare Business Overview
  7.9.3 Siemens Healthcare Glioma Diagnosis and Treatment Major Product Offerings
  7.9.4 Siemens Healthcare Glioma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.9.5 Siemens Healthcare Key News
7.10 Philips Healthcare
  7.10.1 Philips Healthcare Corporate Summary
  7.10.2 Philips Healthcare Business Overview
  7.10.3 Philips Healthcare Glioma Diagnosis and Treatment Major Product Offerings
  7.10.4 Philips Healthcare Glioma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.10.5 Philips Healthcare Key News
7.11 Shimadzu
  7.11.1 Shimadzu Corporate Summary
  7.11.2 Shimadzu Business Overview
  7.11.3 Shimadzu Glioma Diagnosis and Treatment Major Product Offerings
  7.11.4 Shimadzu Glioma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.11.5 Shimadzu Key News
7.12 Canon Medical Systems
  7.12.1 Canon Medical Systems Corporate Summary
  7.12.2 Canon Medical Systems Business Overview
  7.12.3 Canon Medical Systems Glioma Diagnosis and Treatment Major Product Offerings
  7.12.4 Canon Medical Systems Glioma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.12.5 Canon Medical Systems Key News
7.13 Merck
  7.13.1 Merck Corporate Summary
  7.13.2 Merck Business Overview
  7.13.3 Merck Glioma Diagnosis and Treatment Major Product Offerings
  7.13.4 Merck Glioma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.13.5 Merck Key News
7.14 Roche
  7.14.1 Roche Corporate Summary
  7.14.2 Roche Business Overview
  7.14.3 Roche Glioma Diagnosis and Treatment Major Product Offerings
  7.14.4 Roche Glioma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.14.5 Roche Key News
7.15 Arbor Pharmaceuticals
  7.15.1 Arbor Pharmaceuticals Corporate Summary
  7.15.2 Arbor Pharmaceuticals Business Overview
  7.15.3 Arbor Pharmaceuticals Glioma Diagnosis and Treatment Major Product Offerings
  7.15.4 Arbor Pharmaceuticals Glioma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.15.5 Arbor Pharmaceuticals Key News
7.16 Sun Pharmaceutical
  7.16.1 Sun Pharmaceutical Corporate Summary
  7.16.2 Sun Pharmaceutical Business Overview
  7.16.3 Sun Pharmaceutical Glioma Diagnosis and Treatment Major Product Offerings
  7.16.4 Sun Pharmaceutical Glioma Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.16.5 Sun Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Glioma Diagnosis and Treatment Market Opportunities & Trends in Global Market
Table 2. Glioma Diagnosis and Treatment Market Drivers in Global Market
Table 3. Glioma Diagnosis and Treatment Market Restraints in Global Market
Table 4. Key Players of Glioma Diagnosis and Treatment in Global Market
Table 5. Top Glioma Diagnosis and Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Glioma Diagnosis and Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Glioma Diagnosis and Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Glioma Diagnosis and Treatment Product Type
Table 9. List of Global Tier 1 Glioma Diagnosis and Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glioma Diagnosis and Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Glioma Diagnosis and Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Glioma Diagnosis and Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Glioma Diagnosis and Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Glioma Diagnosis and Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Glioma Diagnosis and Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Glioma Diagnosis and Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific Glioma Diagnosis and Treatment Product Offerings
Table 32. Thermo Fisher Scientific Glioma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Emcure Pharmaceuticals Corporate Summary
Table 34. Emcure Pharmaceuticals Glioma Diagnosis and Treatment Product Offerings
Table 35. Emcure Pharmaceuticals Glioma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Sigma-Aldrich Corporate Summary
Table 37. Sigma-Aldrich Glioma Diagnosis and Treatment Product Offerings
Table 38. Sigma-Aldrich Glioma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Glioma Diagnosis and Treatment Product Offerings
Table 41. Pfizer Glioma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Taj Pharmaceuticals Corporate Summary
Table 43. Taj Pharmaceuticals Glioma Diagnosis and Treatment Product Offerings
Table 44. Taj Pharmaceuticals Glioma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Novartis International Corporate Summary
Table 46. Novartis International Glioma Diagnosis and Treatment Product Offerings
Table 47. Novartis International Glioma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Teva Pharmaceutical Corporate Summary
Table 49. Teva Pharmaceutical Glioma Diagnosis and Treatment Product Offerings
Table 50. Teva Pharmaceutical Glioma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 51. GE Healthcare Corporate Summary
Table 52. GE Healthcare Glioma Diagnosis and Treatment Product Offerings
Table 53. GE Healthcare Glioma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Siemens Healthcare Corporate Summary
Table 55. Siemens Healthcare Glioma Diagnosis and Treatment Product Offerings
Table 56. Siemens Healthcare Glioma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Philips Healthcare Corporate Summary
Table 58. Philips Healthcare Glioma Diagnosis and Treatment Product Offerings
Table 59. Philips Healthcare Glioma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Shimadzu Corporate Summary
Table 61. Shimadzu Glioma Diagnosis and Treatment Product Offerings
Table 62. Shimadzu Glioma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Canon Medical Systems Corporate Summary
Table 64. Canon Medical Systems Glioma Diagnosis and Treatment Product Offerings
Table 65. Canon Medical Systems Glioma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Merck Corporate Summary
Table 67. Merck Glioma Diagnosis and Treatment Product Offerings
Table 68. Merck Glioma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Roche Corporate Summary
Table 70. Roche Glioma Diagnosis and Treatment Product Offerings
Table 71. Roche Glioma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Arbor Pharmaceuticals Corporate Summary
Table 73. Arbor Pharmaceuticals Glioma Diagnosis and Treatment Product Offerings
Table 74. Arbor Pharmaceuticals Glioma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Sun Pharmaceutical Corporate Summary
Table 76. Sun Pharmaceutical Glioma Diagnosis and Treatment Product Offerings
Table 77. Sun Pharmaceutical Glioma Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Glioma Diagnosis and Treatment Segment by Type in 2021
Figure 2. Glioma Diagnosis and Treatment Segment by Application in 2021
Figure 3. Global Glioma Diagnosis and Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Glioma Diagnosis and Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Glioma Diagnosis and Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Glioma Diagnosis and Treatment Revenue in 2021
Figure 8. By Type - Global Glioma Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Glioma Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Glioma Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Glioma Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 12. US Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Glioma Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Glioma Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 24. China Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Glioma Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Glioma Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Glioma Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific Glioma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Emcure Pharmaceuticals Glioma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sigma-Aldrich Glioma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Glioma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Taj Pharmaceuticals Glioma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis International Glioma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Teva Pharmaceutical Glioma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GE Healthcare Glioma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Siemens Healthcare Glioma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Philips Healthcare Glioma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Shimadzu Glioma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Canon Medical Systems Glioma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Merck Glioma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Roche Glioma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Arbor Pharmaceuticals Glioma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Sun Pharmaceutical Glioma Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)